Prelude Therapeutics

PRLD

Börsenwert 275 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	BBA 1 Baker Bros. Advisors New York	57,7 Mio. $	–	–	–
2	2 OrbiMed New York	57,2 Mio. $	–	–	–
3	3 Fidelity Investments Boston, Massachusetts	25,9 Mio. $	-261.763 $	-42.914	-0,9 %
4	4 UBS AM Chicago, Illinois	13 Mio. $	-378.486 $	-62.050	-3 %
5	5 Vanguard Group Malvern, Pennsylvania	5,22 Mio. $	+101.865 $	+16.700	+2 %
6	6 Boxer Capital San Diego, California	3,98 Mio. $	+4,26 Mio. $	+699.047	Neu
7	7 Massachusetts Financial Services Boston, Massachusetts	2,93 Mio. $	-2.580 $	-423	-0,1 %
8	8 BlackRock New York	2,41 Mio. $	+179.789 $	+29.475	+7 %
9	9 T. Rowe Price Associates Baltimore, Maryland	1,62 Mio. $	-99.517 $	-16.315	-5 %
10	10 Geode Capital Management Boston, Massachusetts	831.652 $	+7.484 $	+1.227	+0,8 %
11	11 Morgan Stanley New York	807.474 $	+315.434 $	+51.713	+57 %
12	12 Renaissance Technologies New York	789.000 $	+12.199 $	+2.000	+1 %
13	13 Millennium Management New York	778.000 $	+529.350 $	+86.783	+174 %
14	14 Susquehanna International Group Bala Cynwyd, Pennsylvania	739.176 $	+221.968 $	+36.390	+39 %
15	15 State of Wisconsin Investment Board Madison, Wisconsin	514.140 $	-62.217 $	-10.200	-10 %
16	16 Jacobs Levy Equity Management Florham Park, New Jersey	482.602 $	+516.443 $	+84.667	Neu
17	17 Citigroup New York	403.372 $	+65.236 $	+10.695	+18 %
18	18 Jane Street New York	367.479 $	+290.730 $	+47.663	+284 %
19	19 Charles Schwab San Francisco, California	358.251 $	-5.307 $	-870	-1 %
20	20 Two Sigma Advisers New York	287.850 $	-151.273 $	-24.800	-33 %
21	21 Goldman Sachs New York	282.127 $	+205.755 $	+33.732	+214 %
22	22 GSA Capital Partners London, United Kingdom	271.000 $	-1.141 $	-187	-0,4 %
23	23 D.E. Shaw & Co New York	269.319 $	-126.605 $	-20.756	-31 %
24	24 State Street Boston, Massachusetts	250.167 $	–	–	–
25	25 Bridgeway Capital Management Houston, Texas	210.609 $	–	–	–

Prelude Therapeutics PRLD Börsenwert 275 Mio. $

Prelude Therapeutics

PRLD

Börsenwert 275 Mio. $